Gaul C, Diener HC, Müller OM. Cluster headache: clinical features and therapeutic options. Dtsch Arztebl Int 2011; 108(33): 543-549.
Gemeinsamer Bundesausschuss (G-BA). Tragende Gründe zum Beschluss des Gemeinsamen Bundesausschusses über die Änderung der Arzneimittel-Richtlinie (AM-RL): Anlage VI – Off-Label-Use Verapamil zur Prophylaxe des Clusterkopfschmerzes. 2012.
Hacke W. Neurologie. Berlin: Springer; 2016.
Hoffmann J, May A. Diagnosis, pathophysiology, and management of cluster headache. Lancet Neurol 2018; 17(1): 75-83.
International Headache Society (IHS). Die Internationalen Klassifikation von Kopfschmerzerkrankungen, 3. Auflage – ICHD-3. 2018.
May A, Evers S, Brössner G et al. Leitlinie zur Diagnostik, Therapie und Prophylaxe von Cluster-Kopfschmerz, anderen trigeminoautonomen Kopfschmerzen, schlafgebundenem Kopfschmerz und idiopathisch stechenden Kopfschmerzen. Nervenheilkunde 2016; 35: 137-151.
Robbins MS, Starling AJ, Pringsheim TM et al. Treatment of Cluster Headache: The American Headache Society Evidence-Based Guidelines. Headache 2016; 56(7): 1093-1106.
IQWiG health information is written with the aim of helping people understand the advantages and disadvantages of the main treatment options and health care services.
Because IQWiG is a German institute, some of the information provided here is specific to the German health care system. The suitability of any of the described options in an individual case can be determined by talking to a doctor. informedhealth.org can provide support for talks with doctors and other medical professionals, but cannot replace them. We do not offer individual consultations.
Our information is based on the results of good-quality studies. It is written by a team of health care professionals, scientists and editors, and reviewed by external experts. You can find a detailed description of how our health information is produced and updated in our methods.